Abian Darou, a subsidiary of Golrang Pharmaceutical Investment Group, has successfully obtained the GMP (Good Manufacturing Practice) certification, signaling a significant milestone in its strategy to expand into international pharmaceutical markets.
According to the Golrang Pharmaceutical Group Public Relations Department, this certification marks a key development in Abian Darou’s commitment to enhancing global market access and strengthening its export portfolio.
GMP certification is a critical requirement for entering international markets, ensuring that a company’s manufacturing processes meet stringent global standards for product quality, safety, and efficacy. Regulatory authorities conduct rigorous inspections to ensure continuous compliance with these standards.
Enhancing Global Competitiveness
The achievement of Export GMP certification not only elevates Abian Darou’s international credibility but also brings several strategic benefits:
-
Enhanced product quality
-
Reduced production waste
-
Improved operational efficiency
-
Easier clearance of international audits
-
Increased global competitiveness
This success reflects a strategic step toward pharmaceutical self-sufficiency and positions Golrang Pharmaceutical Group more firmly within the global medicinal supply chain.
“Abian Darou’s attainment of GMP certification is a testament to our commitment to world-class manufacturing practices and global expansion,” said a company representative. “We are dedicated to playing an active and enduring role in international pharmaceutical markets.”
